Diametric Capital’s Bristol-Myers Squibb BMY Stock Holding History

Diametric Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,240	Closed	-$296K	–	235
2024 Q4	$296K	Buy	+5,240	New	+$293K	0.2%	158
2023 Q3	–	Sell	-5,373	Closed	-$344K	–	348
2023 Q2	$344K	Buy	+5,373	New	+$360K	0.15%	176
2022 Q4	–	Sell	-37,584	Closed	-$2.67M	–	310
2022 Q3	$2.67M	Buy	+37,584	New	+$2.73M	1.35%	9
2020 Q3	–	Sell	-16,982	Closed	-$999K	–	127
2020 Q2	$999K	Buy	+16,982	New	+$1.02M	0.77%	51
2020 Q1	–	Sell	-40,901	Closed	-$2.63M	–	124
2019 Q4	$2.63M	Sell	40,901 -14,164	-26%	-$811K	1.92%	11
2019 Q3	$2.77M	Buy	+55,065	New	+$2.59M	2.28%	9
2019 Q1	–	Sell	-26,815	Closed	-$1.38M	–	103
2018 Q4	$1.38M	Buy	26,815 +8,535	+47%	+$459K	1.07%	40
2018 Q3	$1.13M	Sell	18,280 -4,799	-21%	-$285K	0.98%	41
2018 Q2	$1.28M	Sell	23,079 -1,856	-7%	-$100K	1.2%	39
2018 Q1	$1.58M	Sell	24,935 -8,077	-24%	-$520K	1.19%	34
2017 Q4	$2.02M	Buy	+33,012	New	+$2.06M	1.23%	28

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Diametric Capital's BMY Position: Q1 2025 in Review

Diametric Capital sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 5,240 shares — an estimated $296K sold.

Diametric Capital first reported a position in BMY in Q4 2017 and held it in 11 quarters. The position peaked at $2.77M in Q3 2019. 2,477 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

Diametric Capital reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
Diametric Capital sold 5,240 Bristol-Myers Squibb shares in Q1 2025, an estimated $296K.
Diametric Capital first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 11 quarters.
Diametric Capital's Bristol-Myers Squibb position peaked at $2.77M in Q3 2019.
2,477 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Diametric Capital's 13F filing for Q1 2025, filed 14 May 2025.